FDA Adverse Event Injury Summary report: N

NAVISWISS HIP NAVIGATION SYSTEM

MDR report key: 18120035 · Received November 13, 2023

Report

Report Number
3017123055-2023-00001
Event Type
Injury
Date Received
November 13, 2023
Date of Event
October 24, 2022
Report Date
November 13, 2023
Manufacturer
NAVISWISS AG
Product Code
OLO
PMA / PMN Number
K193094
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
CO, US
Reporter Occupation
PHYSICIAN
Health Professional
Yes

Narratives

Additional Manufacturer Narrative · 0

AFTER A THOROUGH REVIEW OF THE EQUIPMENT AND PROCEDURAL ASPECTS AT THE HOSPITAL AND GIVEN THE ISOLATED AND CLUSTERED OCCURRENCE OF THESE INFECTIONS, IT IS SURGEONS OPINION THAT THESE INFECTIONS WERE UNRELATED TO THE NAVISWISS TECHNOLOGY. RATHER, IT APPEARS TO BE A RESULT OF BASIC PROCEDURAL ISSUES WITHIN THE RE-PROCESSING DEPARTMENT, WHICH HAVE NOW BEEN RECTIFIED THROUGH ADDITIONAL TRAINING MEASURES. THESE TRAINING MEASURES WERE CARRIED OUT ON APRIL 19TH, 2023 AND INCLUDED A THOROUGH REVIEW OF BASIC HYGIENIC PROCESSES AND THE WELL DESCRIBED NAVISWISS RE-PROCESSING INSTRUCTIONS. FOLLOWING THIS INITIATIVE, THE ISSUE HAS NOT RECURRED. AGAIN, IT IS SURGEON OPINION THAT THESE 3X CASES OF POST-OPERATIVE INFECTION WERE UNRELATED TO THE NAVISWISS PLATFORM. PRODUCT WAS NOT RETURNED FOR INVESTIGATION.

Additional Manufacturer Narrative · 0

NAVISWISS REPORTED THREE CASES IN ONE REPORT. NAVISWISS ADMITS THAT AT THE TIME OF REPORTING THE EVENT, IT WAS NOT AWARE THAT A SEPARATE REPORT WAS REQUIRED FOR EACH EVENT IN A SERIES OF REPORTABLE MDR EVENTS, AS REQUIRED BY THE FDA GUIDANCE DOCUMENT "MEDICAL DEVICE REPORTING FOR MANUFACTURERS, GUIDANCE FOR INDUSTRY AND FOOD AND DRUG ADMINISTRATION STAFF". THE CURRENT REPORT IS INTENDED TO REMEDY THE OMISSION OF NOT HAVING SUBMITTED A SEPARATE MDR REPORT FOR EACH EVENT. PLEASE REFER TO FOLLOWING NEW REPORTS: - MDR 3017123055-2024-00002.

Description of Event or Problem · 0

A SURGEON PERFORMED A REVIEW OF HIS MOST RECENT 118 TOTAL HIP ARTHROPLASTY (THA) CASES THAT INVOLVED THE USE OF THE NAVISWISS TECHNOLOGY. THIS REVIEW WAS TRIGGERED BY THE INCIDENCE OF 3 OUT OF 118 CASES PRESENTING WITH POST-OPERATIVE INFECTION THAT REQUIRED ONGOING MANAGEMENT. THE SINGLE INCIDENTS OCCURED IN (B)(6) 2022 AND WERE NOT REPORTED AS SINGLE INCIDENTS TO NAVISWISS. IN MARCH 2023 NAVISWISS WAS INFORMED REGARDING THE SITUATION. NO ALLEGATION WAS MADE AGAINST THE MEDICAL DEVICE, FURTHERMORE THE SURGEON LOCATED THE ROOT CAUSE IN THE IN-HOUSE REPROCESSING PROCESS (NON-COMPLIANCE). SEE ALSO SECTION B7. NAVISWISS CONSIDERED THIS CASE AS NOT REPORTABLE, AS THE DEVICE, ACCORDING TO THE SURGEON, WAS NOT THE CAUSE OF THE INFECTIONS. DURING AN AUDIT THIS CASE WAS REVIEWED AND CONSIDERED AS REPORTABLE. THIS CAUSED A DELAY IN REPORTING.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
2162037 NAVISWISS HIP NAVIGATION SYSTEM NAVISWISS HIP NAVIGATION SYSTEM OLO NAVISWISS AG

Patients

Seq Age Sex Outcome Treatment
1 NA Unknown Other